Xylem Inc.
NYSE:XYL
118.47 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,364 | 5,522 | 5,195 | 4,876 | 5,249 | 5,207 | 4,707 | 3,771 | 3,653 | 3,916 | 3,837 | 3,791 | 3,803 | 3,202 | 2,849 |
| Cost of Revenue
| 4,647 | 3,438 | 3,220 | 3,046 | 3,203 | 3,181 | 2,856 | 2,310 | 2,249 | 2,403 | 2,338 | 2,289 | 2,342 | 1,988 | 1,812 |
| Gross Profit
| 2,717 | 2,084 | 1,975 | 1,830 | 2,046 | 2,026 | 1,851 | 1,461 | 1,404 | 1,513 | 1,499 | 1,502 | 1,461 | 1,214 | 1,037 |
| Gross Profit Ratio
| 0.369 | 0.377 | 0.38 | 0.375 | 0.39 | 0.389 | 0.393 | 0.387 | 0.384 | 0.386 | 0.391 | 0.396 | 0.384 | 0.379 | 0.364 |
| Reseach & Development Expenses
| 232 | 206 | 204 | 187 | 191 | 189 | 180 | 110 | 95 | 104 | 104 | 106 | 100 | 74 | 63 |
| General & Administrative Expenses
| 1,757 | 1,367 | 1,179 | 1,143 | 1,158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | -140 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,757 | 1,227 | 1,179 | 1,143 | 1,158 | 1,161 | 1,090 | 915 | 854 | 920 | 986 | 914 | 964 | 737 | 667 |
| Other Expenses
| 0 | -133 | -16 | -5 | -4 | 13 | 2 | 4 | -5 | 1 | -10 | -8 | 0 | 0 | 1 |
| Operating Expenses
| 2,065 | 1,433 | 1,383 | 1,330 | 1,349 | 1,350 | 1,270 | 1,025 | 949 | 1,024 | 1,090 | 1,020 | 1,064 | 811 | 730 |
| Operating Income
| 652 | 622 | 585 | 495 | 693 | 654 | 556 | 406 | 449 | 463 | 363 | 443 | 395 | 388 | 276 |
| Operating Income Ratio
| 0.089 | 0.113 | 0.113 | 0.102 | 0.132 | 0.126 | 0.118 | 0.108 | 0.123 | 0.118 | 0.095 | 0.117 | 0.104 | 0.121 | 0.097 |
| Total Other Income Expenses Net
| -17 | -182 | -74 | -82 | -70 | -69 | -86 | -68 | -46 | -42 | -65 | -94 | -12 | -15 | 1 |
| Income Before Tax
| 635 | 440 | 511 | 285 | 416 | 585 | 466 | 340 | 403 | 421 | 298 | 388 | 383 | 388 | 277 |
| Income Before Tax Ratio
| 0.086 | 0.08 | 0.098 | 0.058 | 0.079 | 0.112 | 0.099 | 0.09 | 0.11 | 0.108 | 0.078 | 0.102 | 0.101 | 0.121 | 0.097 |
| Income Tax Expense
| 26 | 85 | 84 | 31 | 15 | 36 | 136 | 80 | 63 | 84 | 70 | 91 | 104 | 59 | 14 |
| Net Income
| 609 | 355 | 427 | 254 | 401 | 549 | 331 | 260 | 340 | 337 | 228 | 297 | 279 | 329 | 263 |
| Net Income Ratio
| 0.083 | 0.064 | 0.082 | 0.052 | 0.076 | 0.105 | 0.07 | 0.069 | 0.093 | 0.086 | 0.059 | 0.078 | 0.073 | 0.103 | 0.092 |
| EPS
| 2.81 | 1.97 | 2.37 | 1.41 | 2.23 | 3.05 | 1.84 | 1.45 | 1.88 | 1.84 | 1.23 | 1.6 | 1.51 | 1.78 | 1.42 |
| EPS Diluted
| 2.79 | 1.96 | 2.35 | 1.4 | 2.21 | 3.03 | 1.83 | 1.45 | 1.87 | 1.83 | 1.22 | 1.59 | 1.5 | 1.78 | 1.42 |
| EBITDA
| 1,150 | 755 | 853 | 736 | 947 | 948 | 814 | 637 | 588 | 631 | 603 | 624 | 537 | 510 | 347 |
| EBITDA Ratio
| 0.156 | 0.137 | 0.161 | 0.153 | 0.181 | 0.182 | 0.174 | 0.157 | 0.161 | 0.161 | 0.143 | 0.165 | 0.142 | 0.159 | 0.143 |